IPOpulse
Sign up
Back to Ticker

AstraZeneca Pharma India Limited

NSE: ASTRAZEN
₹6,039.5
+1.16%EOD · 19 Oct
Market Cap
₹15,099 Cr
52W Range
₹9850 / ₹5640
Volume
14K
57.0% delivery
1Y Return
-34.8%
P/E Ratio
88.0
P/B Ratio
17.1
ROE
22.8%
Debt / Equity
12.68

Quality Score

Durability · Valuation · Momentum — objective math, not advice
D
30/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityGood · 60
ValuationPoor · 10
MomentumPoor · 10
High ROE (22.8%)
High debt load (D/E 12.7)
In confirmed downtrend (Stage 4)
Very expensive valuation (P/E 88x)

Technical Indicators

Full analysis · objective math, not advice
Returns
1D
+1.2%
1W
+2.0%
1M
-9.4%
3M
-25.0%
6M
-29.0%
1Y
-34.8%
Weinstein Stage
Stage 4 — Declining (downtrend)
RSI (14)
39 Neutral
Trend Template
0/7weak
RS vs Nifty (3M)
-20.8pp
Moving Averages (price vs MA)
20-DMA
₹6149
below
50-DMA
₹6796
below
150-DMA
₹7818
below
200-DMA
₹8022
below
From 52W High
-38.7%
From 52W Low
+7.1%
Support (20D)
₹5640
Resistance (20D)
₹6783

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

Sign in to join the discussion.

Sign in

No comments yet — be the first to share your view.